0001104659-12-003524.txt : 20120124 0001104659-12-003524.hdr.sgml : 20120124 20120124094536 ACCESSION NUMBER: 0001104659-12-003524 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20120124 DATE AS OF CHANGE: 20120124 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Hunter Robert Merrill CENTRAL INDEX KEY: 0001507797 FILING VALUES: FORM TYPE: SC 13G MAIL ADDRESS: STREET 1: C/O CALLISTO PHARMACEUTICALS, INC. STREET 2: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TrovaGene Inc. CENTRAL INDEX KEY: 0001213037 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043721895 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-80378 FILM NUMBER: 12541010 BUSINESS ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-217-5420 MAIL ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: XENOMICS INC DATE OF NAME CHANGE: 20040719 FORMER COMPANY: FORMER CONFORMED NAME: USED KAR PARTS INC DATE OF NAME CHANGE: 20030106 SC 13G 1 a12-3214_11sc13g.htm SC 13G

 

 

SECURITIES AND EXCHANGE COMMISSION

 

 

Washington, DC 20549

 

 

 

 

SCHEDULE 13G

(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULE 13d-1(b) (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO

RULE 13d-2(b)

 

(Amendment No.     )

 

TrovaGene, Inc.

(Name of Issuer)

Common Stock, $.0001 per share

(Title of Class of Securities)

897238 10 1

(CUSIP Number)

January 23, 2012

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

o

Rule 13d-1(b)

x

Rule 13d-1(c)

o

Rule 13d-1(d)

 


 

CUSIP No. 897238 10 1

13G

 

 

 

1

Name of Reporting Persons
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

R. Merrill Hunter

 

 

2

Check the Appropriate Box if a Member of a Group*

 

 

(a)

o

 

 

(b)

o

 

 

3

SEC Use Only

 

 

4

Citizenship or Place of Organization
USA

 

 

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

5

Sole Voting Power
8,265,004(1)

 

6

Shared Voting Power
0

 

7

Sole Dispositive Power
8,265,004(1)

 

8

Shared Dispositive Power
0

 

 

9

Aggregate Amount Beneficially Owned by Each Reporting Person
8,265,004 (1)

 

 

10

Check box if the Aggregate Amount in Row (9) Excludes Certain Shares  o

 

 

13

Percent of Class Represented by Amount in Row 9
12.2 (2)

 

 

14

Type of Reporting Person*
IN

 

(1)   Includes 3,600,000 shares of common stock issuable upon exercise of warrants.

 

(2)   Based upon an aggregate of 64,422,157 shares of the Issuer’s issued and outstanding common stock as of January 23, 2012.

 

2


 

Item 1

(a).

Name of Issuer:
TrovaGene, Inc.

Item 1

(b).

Address of Issuer’s Principal Executive Offices:
11055 Flintkote Avenue, San Diego, CA 92121.

 

Item 2

(a).

Name of Person Filing.

 

(b).

Address of Principal Business Office or, if none, Residence.
R. Merrill Hunter

c/o TrovaGene, Inc.

11055 Flintkote Avenue

San Diego, CA 92121

 

(c).

Citizenship.
USA

Item 2

(d).

Title of Class of Securities.
Common Stock, $.0001 par value

Item 2

(e).

CUSIP Number.
897238 10 1

 

Item 3.

If this Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b or (c), Check Whether the Person Filing is a:

 

(a)

o

Broker or dealer registered under Section 15 of the Exchange Act.

 

(b)

o

Bank as defined in Section 3(a)(6) of the Exchange Act.

 

(c)

o

Insurance Company as defined in Section 3(a)(19) of the Exchange Act.

 

(d)

o

Investment Company registered under Section 8 of the Investment Company Act.

 

(e)

o

An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).

 

(f)

o

An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).

 

(g)

o

A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).

 

(h)

o

A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.

 

(i)

o

A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act.

 

(j)

o

Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

 

3


 

Item 4.

Ownership.

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

(a)

Amount beneficially owned:   

8,265,004

 

(b)

Percent of class:   

12.2%

 

(c)

Number of shares as to which such person has:

 

 

 

(i)

Sole power to vote or to direct the vote:   

8,265,004

 

 

(ii)

Shared power to vote or to direct the vote:    

0

 

 

(iii)

Sole power to dispose or to direct the disposition of:  

8,265,004

 

 

(iv)

Shared power to dispose or to direct the disposition of:   

0

 

Item 5.

Ownership of Five Percent or Less of a Class.

 

Not applicable.

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

 

Not Applicable

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported by the Parent Holding Company or Control Person.

 

Not applicable.

 

Item 8.

Identification and Classification of Members of the Group.

 

Not applicable.

 

Item 9.

Notice of Dissolution of Group.

 

Not applicable.

 

 

4


 

Item 10.

Certifications.

By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect.

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

 

Date: January 23, 2012

 

 

 

R. Merrill Hunter

 

 

 

/s/ R. Merrill Hunter

 

5